Allergies are no longer seasonal inconveniences—they have become year-round health concerns for millions of Indians. From dust allergies and pollen sensitivity to food reactions and skin […]
Union Budget 2026, unveiled by Finance Minister Nirmala Sitharaman, put a strong spotlight on healthcare, especially with the ambitious Biopharma SHAKTI scheme — a transformative initiative […]
Diabetes has emerged as one of the most critical public health challenges in India, creating a strong and ever-growing demand for high-quality, affordable, and innovative diabetic […]
As the Indian pharmaceutical industry stands on the cusp of a major regulatory shift, the revised Schedule M norms are set to be enforced as scheduled, […]
India’s pharmaceutical industry has long been celebrated as the “pharmacy of the world,” a key supplier of generic medicines across the globe. However, this reputation has […]
The Indian pharmaceutical sector is once again in the global spotlight, and this time Wockhardt is leading the charge. In a remarkable market performance, Wockhardt’s share […]
In a deeply troubling turn of events, India’s drug regulator has moved swiftly in response to a spate of child fatalities linked to contaminated cough syrups. […]
India is often dubbed the “diabetes capital of the world,” with over 100 million people grappling with this chronic illness. On World Diabetes Day, the spotlight […]
Antibiotics remain the backbone of modern healthcare, and with rising bacterial infections, expanding medical infrastructure, and increasing patient awareness, the demand for high-quality antibacterial medicines is […]